Peptide Vials (GHK-Cu, 100 mg each): 5 days/week (1.0-2.0 mg/day): 8 weeks (~50 mg total): 1 vial 12 weeks (~90 mg total): 1 vial 16 weeks (~130 mg total): 2 vials 3 times/week (2 mg each): 8 weeks (~48 mg total): 1 vial 12 weeks (~72 mg total): 1 vial 16 weeks (~96 mg total): 1 vial Insulin Syringes (U-100, 29-31 gauge): 5 days/week: Per week: 5 syringes 8 weeks: 40 syringes 12 weeks: 60 syringes 16 weeks: 80 syringes 3 times/week: Per week: 3 syringes 8 weeks: 24 syringes 12 weeks: 36 syringes 16 weeks: 48 syringes Sterile or Bacteriostatic Water (10 mL bottles): Use 3.0 mL per vial for the displayed calculation
Minimize Exposure: When you draw the solution, work efficiently
Ayabe T, Satchell DP, Wilson CL, Parks WC, Selsted ME, Ouellette AJ: Secretion of microbicidal -defensins by intestinal Paneth cells in response to bacteria
Most users find these gastrointestinal effects subside over time as the body adjusts, but some people cannot tolerate the medication at all
Thymosin Beta-4 functions as the principal regulator of monomeric actin availability in most cell types, sequestering approximately 40-50% of the total G-actin pool